Loading…
Tecan Group agreed to acquire certain assets relating to four ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of Revvity. The asset purchase includes the manufacturing process of two IVD kits and two RUO kits.
Tecan Group has entered into a definitive agreement to acquire Paramit Corporation, a US-based OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million). The acquisition will expand Tecan's capabilities in medical devices and strengthen its US and Asia presence.